Workup for Elevated Testosterone and Progesterone in Males
The workup for a male with elevated testosterone and progesterone that is not exogenous or iatrogenic should include comprehensive endocrine evaluation, imaging studies, and genetic testing to rule out adrenal, testicular, or neoplastic causes.
Initial Evaluation
Laboratory Assessment
Confirm elevated hormone levels
- Repeat morning total testosterone and progesterone measurements to confirm elevation
- Measure free testosterone using equilibrium dialysis or accurate calculation formula 1
- Assess bioavailable testosterone
Basic hormonal workup
- Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
- Low or suppressed LH/FSH with elevated testosterone suggests autonomous production 1
- Normal/elevated LH/FSH may indicate receptor insensitivity
- Estradiol levels (testosterone can be aromatized to estrogen) 2
- Prolactin (to rule out hyperprolactinemia) 1
- Human chorionic gonadotropin (hCG) (marker for certain tumors)
- Alpha-fetoprotein (AFP) (marker for certain tumors) 1
- Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
Additional hormone testing
- Adrenal hormone panel:
- DHEA-sulfate
- 17-hydroxyprogesterone
- Androstenedione
- Cortisol (morning and evening)
- 24-hour urinary steroid profile
- Adrenal hormone panel:
Imaging Studies
Testicular ultrasound
- To evaluate for testicular tumors (Leydig cell tumors can produce both testosterone and progesterone)
Adrenal imaging
- CT or MRI of adrenal glands to evaluate for adrenal tumors or hyperplasia
Pituitary MRI
- If LH/FSH levels are inappropriately normal or elevated despite high testosterone
Whole-body imaging
- Consider FDG-PET/CT if malignancy is suspected 1
Differential Diagnosis
Testicular Causes
- Leydig cell tumors (can produce both testosterone and progesterone)
- Testicular adrenal rest tumors (in congenital adrenal hyperplasia)
Adrenal Causes
- Adrenal tumors (adenoma or carcinoma)
- Congenital adrenal hyperplasia (particularly late-onset forms)
- Adrenal hyperplasia
Neoplastic Causes
- Ectopic hCG-producing tumors (lung, liver, kidney)
- Paraneoplastic syndromes
Genetic/Enzymatic Disorders
- Enzyme deficiencies in steroidogenesis pathway
- Androgen receptor mutations
Specialized Testing
Genetic testing
- Karyotype analysis if chromosomal abnormality is suspected 1
- Testing for congenital adrenal hyperplasia genes (CYP21A2, CYP11B1)
Stimulation/Suppression tests
- ACTH stimulation test to evaluate adrenal function
- Dexamethasone suppression test to differentiate between adrenal and other sources
Tissue biopsy
- If imaging identifies a suspicious mass
Clinical Implications and Monitoring
Potential Health Consequences
- Monitor for polycythemia (hematocrit >50%) 1, 3
- Assess cardiovascular risk factors 1, 3
- Evaluate for gynecomastia (from estrogen conversion) 2
- Monitor prostate health with PSA and digital rectal examination 1
- Assess for sleep apnea 3
- Evaluate fertility status (elevated testosterone can suppress spermatogenesis) 4, 5
Follow-up
- Regular monitoring of hormone levels
- Periodic imaging based on initial findings
- Monitoring of symptoms and potential complications
Treatment Considerations
Treatment should be directed at the underlying cause:
- Surgical removal for tumors
- Medical management for enzymatic disorders
- Symptomatic treatment for complications
Common Pitfalls
Failing to confirm elevated levels - Testosterone has diurnal variation; morning samples are essential 6
Missing exogenous sources - Thoroughly investigate supplements, topical exposures, and environmental contamination
Overlooking partial enzyme deficiencies - These can present in adulthood with subtle symptoms
Focusing only on testosterone - The elevated progesterone is a key diagnostic clue that may point to specific enzyme deficiencies or tumors 7
Inadequate imaging - Small adrenal or testicular tumors can be missed without proper protocols
Remember that elevated testosterone and progesterone in males is uncommon and warrants thorough investigation, as it may indicate serious underlying pathology including tumors or enzymatic disorders.